VERTEX PHARMACEUTICALS INC / MA Insider Trading for March 2017
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in VERTEX PHARMACEUTICALS INC / MA.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in VERTEX PHARMACEUTICALS INC / MA for March 2017.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 31 2017 | VRTX | VERTEX PHARMACEUTI ... | Silva Paul M | SVP & Corp Controll ... | Option Exercise | M | 45.11 | 1,688 | 76,146 | 8,438 | |
| Mar 31 2017 | VRTX | VERTEX PHARMACEUTI ... | Silva Paul M | SVP & Corp Controll ... | Sell | S | 106.30 | 1,688 | 179,434 | 20,071 | 21.8 K to 20.1 K (-7.76 %) |
| Mar 31 2017 | VRTX | VERTEX PHARMACEUTI ... | Silva Paul M | SVP & Corp Controll ... | Buy | M | 45.11 | 1,688 | 76,146 | 21,759 | 20.1 K to 21.8 K (+8.41 %) |
| Mar 31 2017 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, CRO | Option Exercise | M | 45.11 | 28,593 | 1,289,830 | 0 | |
| Mar 31 2017 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, CRO | Option Exercise | M | 48.74 | 29,032 | 1,415,020 | 0 | |
| Mar 31 2017 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, CRO | Option Exercise | M | 37.86 | 17,156 | 649,526 | 0 | |
| Mar 31 2017 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, CRO | Option Exercise | M | 38.80 | 5,719 | 221,897 | 0 | |
| Mar 31 2017 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, CRO | Sell | S | 110.00 | 29,032 | 3,193,520 | 99,335 | 128.4 K to 99.3 K (-22.62 %) |
| Mar 31 2017 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, CRO | Sell | S | 106.30 | 51,468 | 5,471,048 | 128,367 | 179.8 K to 128.4 K (-28.62 %) |
| Mar 31 2017 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, CRO | Buy | M | 45.11 | 28,593 | 1,289,830 | 179,835 | 151.2 K to 179.8 K (+18.91 %) |
| Mar 31 2017 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, CRO | Buy | M | 48.74 | 29,032 | 1,415,020 | 151,242 | 122.2 K to 151.2 K (+23.76 %) |
| Mar 31 2017 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, CRO | Buy | M | 37.86 | 17,156 | 649,526 | 122,210 | 105.1 K to 122.2 K (+16.33 %) |
| Mar 31 2017 | VRTX | VERTEX PHARMACEUTI ... | Sachdev Amit | EVP, CRO | Buy | M | 38.80 | 5,719 | 221,897 | 105,054 | 99.3 K to 105.1 K (+5.76 %) |
| Mar 31 2017 | VRTX | VERTEX PHARMACEUTI ... | Chodakewitz Jeffrey | EVP GMDA, CMO | Option Exercise | M | 73.51 | 13,750 | 1,010,763 | 20,625 | |
| Mar 31 2017 | VRTX | VERTEX PHARMACEUTI ... | Chodakewitz Jeffrey | EVP GMDA, CMO | Sell | S | 106.65 | 13,750 | 1,466,438 | 122,511 | 136.3 K to 122.5 K (-10.09 %) |
| Mar 31 2017 | VRTX | VERTEX PHARMACEUTI ... | Chodakewitz Jeffrey | EVP GMDA, CMO | Buy | M | 73.51 | 13,750 | 1,010,763 | 136,261 | 122.5 K to 136.3 K (+11.22 %) |